These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22778857)

  • 1. Medicinal chemistry of competitive kainate receptor antagonists.
    Larsen AM; Bunch L
    ACS Chem Neurosci; 2011 Feb; 2(2):60-74. PubMed ID: 22778857
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Møllerud S; Hansen RB; Pallesen J; Temperini P; Pasini D; Bornholt J; Nielsen B; Mamedova E; Chalupnik P; Paternain AV; Lerma J; Diaz-delCastillo M; Andreasen JT; Frydenvang K; Kastrup JS; Johansen TN; Pickering DS
    ACS Chem Neurosci; 2019 Nov; 10(11):4685-4695. PubMed ID: 31622082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N1-Substituted Quinoxaline-2,3-diones as Kainate Receptor Antagonists: X-ray Crystallography, Structure-Affinity Relationships, and in Vitro Pharmacology.
    Pallesen J; Møllerud S; Frydenvang K; Pickering DS; Bornholdt J; Nielsen B; Pasini D; Han L; Marconi L; Kastrup JS; Johansen TN
    ACS Chem Neurosci; 2019 Mar; 10(3):1841-1853. PubMed ID: 30620174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310.
    Atlason PT; Scholefield CL; Eaves RJ; Mayo-Martin MB; Jane DE; Molnár E
    Mol Pharmacol; 2010 Dec; 78(6):1036-45. PubMed ID: 20837679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding mode of an α-amino acid-linked quinoxaline-2,3-dione analogue at glutamate receptor subtype GluK1.
    Demmer CS; Møller C; Brown PM; Han L; Pickering DS; Nielsen B; Bowie D; Frydenvang K; Kastrup JS; Bunch L
    ACS Chem Neurosci; 2015 Jun; 6(6):845-54. PubMed ID: 25856736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding site and ligand flexibility revealed by high resolution crystal structures of GluK1 competitive antagonists.
    Alushin GM; Jane D; Mayer ML
    Neuropharmacology; 2011 Jan; 60(1):126-34. PubMed ID: 20558186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural studies, homology modeling and molecular docking of novel non-competitive antagonists of GluK1/GluK2 receptors.
    Kaczor AA; Karczmarzyk Z; Fruziński A; Pihlaja K; Sinkkonen J; Wiinämaki K; Kronbach C; Unverferth K; Poso A; Matosiuk D
    Bioorg Med Chem; 2014 Jan; 22(2):787-95. PubMed ID: 24368028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and pharmacological characterization of phenylalanine-based AMPA receptor antagonists at kainate receptors.
    Venskutonytė R; Frydenvang K; Valadés EA; Szymańska E; Johansen TN; Kastrup JS; Pickering DS
    ChemMedChem; 2012 Oct; 7(10):1793-8. PubMed ID: 22407805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from crystal structures of kainate receptors.
    Møllerud S; Frydenvang K; Pickering DS; Kastrup JS
    Neuropharmacology; 2017 Jan; 112(Pt A):16-28. PubMed ID: 27236079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and Affinity of Two Bicyclic Glutamate Analogues at AMPA and Kainate Receptors.
    Møllerud S; Pinto A; Marconi L; Frydenvang K; Thorsen TS; Laulumaa S; Venskutonytė R; Winther S; Moral AMC; Tamborini L; Conti P; Pickering DS; Kastrup JS
    ACS Chem Neurosci; 2017 Sep; 8(9):2056-2064. PubMed ID: 28691798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of recombinant and native GluK3-containing kainate receptors.
    Perrais D; Pinheiro PS; Jane DE; Mulle C
    Neuropharmacology; 2009 Jan; 56(1):131-40. PubMed ID: 18761361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Synthesis of a Series of l-trans-4-Substituted Prolines as Selective Antagonists for the Ionotropic Glutamate Receptors Including Functional and X-ray Crystallographic Studies of New Subtype Selective Kainic Acid Receptor Subtype 1 (GluK1) Antagonist (2S,4R)-4-(2-Carboxyphenoxy)pyrrolidine-2-carboxylic Acid.
    Krogsgaard-Larsen N; Delgar CG; Koch K; Brown PM; Møller C; Han L; Huynh TH; Hansen SW; Nielsen B; Bowie D; Pickering DS; Kastrup JS; Frydenvang K; Bunch L
    J Med Chem; 2017 Jan; 60(1):441-457. PubMed ID: 28005385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and structure-activity relationships of novel phenylalanine-based amino acids as kainate receptors ligands.
    Szymańska E; Chałupnik P; Szczepańska K; Cuñado Moral AM; Pickering DS; Nielsen B; Johansen TN; Kieć-Kononowicz K
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5568-5572. PubMed ID: 27765511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrrolylquinoxalinediones carrying a piperazine residue represent highly potent and selective ligands to the homomeric kainate receptor GluR5.
    Lubisch W; Behl B; Henn C; Hofmann HP; Reeb J; Regner F; Vierling M
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2113-6. PubMed ID: 12127516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kainate Receptor Antagonists: Recent Advances and Therapeutic Perspective.
    Chałupnik P; Szymańska E
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kainate receptors: pharmacology, function and therapeutic potential.
    Jane DE; Lodge D; Collingridge GL
    Neuropharmacology; 2009 Jan; 56(1):90-113. PubMed ID: 18793656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of kainate receptor-mediated heterosynaptic facilitation of mossy-fiber synapses in KA2-/- mice.
    Contractor A; Sailer AW; Darstein M; Maron C; Xu J; Swanson GT; Heinemann SF
    J Neurosci; 2003 Jan; 23(2):422-9. PubMed ID: 12533602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated plasticity of postsynaptic kainate receptors in hippocampal CA3 pyramidal neurons.
    Ito K; Contractor A; Swanson GT
    J Neurosci; 2004 Jul; 24(27):6228-36. PubMed ID: 15240815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual roles in feeding for AMPA/kainate receptors: receptor activation or inactivation within distinct hypothalamic regions elicits feeding behavior.
    Hettes SR; Gonzaga J; Heyming TW; Perez S; Wolfsohn S; Stanley BG
    Brain Res; 2003 Dec; 992(2):167-78. PubMed ID: 14625056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.